bpc 157 for autism BPC-157 – Research Peptide BPC-157 for Foot Pain |
Description
Cycle Length: Minimum 24 weeks
12, RA130147
The evidence base is overwhelmingly preclinical, and there are no completed, published Phase 2 or 3 human efficacy trials only early-stage safety work [9]
A typical starting-dose vial might contain tirzepatide at 5mg/mL with cyanocobalamin at 2mg/mL
